Based on 4 Wall Street analysts offering 12 month price targets for Amphastar Pharmaceuticals in the last 3 months. The average price target is $61.33 with a high forecast of $70.00 and a low forecast of $48.00. The average price target represents a 31.08% change from the last price of $46.79. Main Points: Future Financial Performance: Amphastar anticipates...
Fundamentals Strong Earnings Growth: WLFC reported a significant increase in EPS, reaching $6.21 in Q2 2024, compared to $2.02 in the prior year, highlighting strong financial performance. Revenue Surge: The company’s total revenue grew by 38.6%, driven by record lease rent and maintenance reserve revenues, indicating robust demand and effective asset...
Fundamentals Significant Upside Potential: Travelzoo's stock has the potential for a 37.5% increase based on Wall Street analysts' mean price target of $15.67, with estimates ranging from $12 to $18. Strong Analyst Agreement: The low standard deviation in price targets suggests strong consensus among analysts, indicating confidence in the stock's upward...
Kingstone Companies Inc is a multi-line regional property and casualty insurance holding company. It offers insurance policies to small and mid-sized businesses as well as to individuals. Significant Market Opportunity: Kingstone is uniquely positioned to capitalize on a profound shift in the New York property insurance market, with competitors exiting the space,...
Upward bullish channel maintained New all time high set by upward break from bullish channel Upward gap Recent earnings release was positive with revenue and earnings beating forcast by 1.94% and 15.45% respectively. Analysts from Citi group price target 512 consider buying and holding for this.
Overall trend is bullish. Recent selloff from all time highs around 490 resulted in bearish channel which was pullback Seller failed to push prices past previous support area of 430. Bearish channel broke by upside gap due to postive earnings release Earnings release : positive earnings and revenue growth beating analysts forecast by 2.29% and 1.59%...
Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance bullish momentum
- Doji Star - Lower lows Lose of buying momentum candlesticks close below moving averages.